Adverum Biotechnologies
(NASDAQ:ADVM)
$2.10
0[0.00%]
At close: Feb 22
$2.10
0[0.00%]
PreMarket: 7:51PM EDT

GET A REPORT ON ADVM SENT RIGHT TO YOUR INBOX

Adverum Biotechnologies Stock (NASDAQ:ADVM), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Buy
Highest Price Target1
$6.00
Lowest Price Target1
$2.00
Consensus Price Target1
$3.80

Analyst Rating Summary1

Analyst Ratings
Sep 23
1
Nov 23
1
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Mizuho
Truist Securities
Chardan Capital
Ladenburg Thalmann
RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Adverum Biotechnologies

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/06/2024ADVMBuy Now
Adverum Biotechnologies
$2.1090.48%Mizuho
Graig Suvannavejh
$2 → $4MaintainsBuyGet Alert
11/02/2023ADVMBuy Now
Adverum Biotechnologies
$2.10-4.76%Mizuho
Graig Suvannavejh
→ $2Initiates → BuyGet Alert
09/05/2023ADVMBuy Now
Adverum Biotechnologies
$2.10185.71%Truist Securities
Joon Lee
→ $6ReiteratesBuy → BuyGet Alert
08/11/2023ADVMBuy Now
Adverum Biotechnologies
$2.1090.48%Chardan Capital
Daniil Gataulin
$2 → $4UpgradeNeutral → BuyGet Alert
03/07/2023ADVMBuy Now
Adverum Biotechnologies
$2.10-4.76%Ladenburg Thalmann
Aydin Huseynov
→ $2Initiates → BuyGet Alert
11/11/2022ADVMBuy Now
Adverum Biotechnologies
$2.10-4.76%Chardan Capital
Daniil Gataulin
$2.5 → $2MaintainsNeutralGet Alert
11/11/2022ADVMBuy Now
Adverum Biotechnologies
$2.1042.86%RBC Capital
Luca Issi
$5 → $3MaintainsSector PerformGet Alert
08/12/2022ADVMBuy Now
Adverum Biotechnologies
$2.1019.05%Chardan Capital
Daniil Gataulin
$3 → $2.5MaintainsNeutralGet Alert
07/07/2022ADVMBuy Now
Adverum Biotechnologies
$2.1090.48%Truist Securities
Joon Lee
$3 → $4UpgradeHold → BuyGet Alert
07/23/2021ADVMBuy Now
Adverum Biotechnologies
$2.1042.86%Chardan Capital
Geulah Livshits
MaintainsNeutralGet Alert
07/23/2021ADVMBuy Now
Adverum Biotechnologies
$2.1042.86%Cantor Fitzgerald
Alethia Young
DowngradeOverweight → NeutralGet Alert
07/23/2021ADVMBuy Now
Adverum Biotechnologies
$2.10-4.76%SVB Leerink
Mani Foroohar
MaintainsMarket PerformGet Alert
05/03/2021ADVMBuy Now
Adverum Biotechnologies
$2.10138.1%SVB Leerink
Mani Foroohar
DowngradeOutperform → Market PerformGet Alert
04/29/2021ADVMBuy Now
Adverum Biotechnologies
$2.10138.1%Chardan Capital
Gbola Amusa
DowngradeBuy → NeutralGet Alert
04/29/2021ADVMBuy Now
Adverum Biotechnologies
$2.10328.57%Truist Securities
Joon Lee
DowngradeBuy → HoldGet Alert
04/29/2021ADVMBuy Now
Adverum Biotechnologies
$2.10185.71%RBC CapitalDowngradeOutperform → Sector PerformGet Alert
04/29/2021ADVMBuy Now
Adverum Biotechnologies
$2.10423.81%SVB Leerink
Mani Foroohar
MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Adverum Biotechnologies (ADVM)?

A

The latest price target for Adverum Biotechnologies (NASDAQ: ADVM) was reported by Mizuho on February 6, 2024. The analyst firm set a price target for $4.00 expecting ADVM to rise to within 12 months (a possible 90.48% upside). 5 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Adverum Biotechnologies (ADVM)?

A

The latest analyst rating for Adverum Biotechnologies (NASDAQ: ADVM) was provided by Mizuho, and Adverum Biotechnologies maintained their buy rating.

Q

When is the next analyst rating going to be posted or updated for Adverum Biotechnologies (ADVM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adverum Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adverum Biotechnologies was filed on February 6, 2024 so you should expect the next rating to be made available sometime around February 6, 2025.

Q

Is the Analyst Rating Adverum Biotechnologies (ADVM) correct?

A

While ratings are subjective and will change, the latest Adverum Biotechnologies (ADVM) rating was a maintained with a price target of $2.00 to $4.00. The current price Adverum Biotechnologies (ADVM) is trading at is $2.10, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch